Type 2 diabetes mellitus

Related records

Broader conditions (11)

• Diabetes mellitus
• Digestive system disorder
• Disease
• Disease by body system or component
• Disease by developmental or physiological process
• Endocrine pancreas disorder
• Endocrine system disorder
• Glucose metabolism disease
• Human disease
• Metabolic disease
• Pancreas disorder

Narrower conditions (6)

• Diabetes mellitus, noninsulin-dependent, 1
• Diabetes mellitus, noninsulin-dependent, 2
• Diabetes mellitus, noninsulin-dependent, 3
• Diabetes mellitus, noninsulin-dependent, 4
• Diabetes mellitus, noninsulin-dependent, 5
• Lipoatrophic diabetes

Trials (10,373)

• -Oleoyl Glycerol is a GPR119 Agonist and Signals GLP-1 Release in Humans.
• : Identification of Non-alcoholic Steato-hepatitis Cases in a Sample of Type 2 Diabetes Patients, with a Disruption of the Liver Function Tests, At the Pointe-à-Pitre University Hospital
• ¡Si, Yo Puedo Control Mi Diabetes!: A Diabetes Self-management Education Program for Hispanic/Latinos
• 'Ai Pono Cooking Demonstrations
• "Can Soluble-CD163 Discriminate Between Healthy and Unhealthy Obese Individuals?"
• "Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"
• "Effect of High Fat and High Glycemic Diets
• "Effect of Omega-3 Supplementation as Add on Therapy on Glycemic Control and Lipid Profile in Type2 Diabetes Mellitus."
• "Effectiveness of Supervised and Unsupervised mHealth-based Exercise Interventions on Clinical Outcomes in Adults With Type 2 Diabetes and Obesity Within a Primary Care Context"
• "Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."
• "Hepatic Substrate Flux Rates in Type 2 Diabetes"
• "Information Technology Methodology for Patient Motivation in Diabetes Management."
• "POWER2DM Evaluation Campaign"
• "Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population
• "Screening for Change: Early Risk Detection and Integrated Prevention for Diabetes and Cardiovascular Diseases in the Marche Region"
• "Sexual Activity and Hypoglycemia Risk in Adults With Type 1 or Type 2 Diabetes Using Insulin Therapy and Continuous Glucose Monitoring"
• "Shoulder Musculoskeletal Disorders in Type 2 Diabetes Mellitus: Contributing Factors and Rehabilitation Protocol"
• "TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM
• "The Effect of Comprehensive Non-pharmacological Treatment on Metabolic Disorders in Type 2 Diabetic Patients"
• "Ultrasound-Enhanced Propolis Therapy for Healing Diabetic Foot Wounds"

Approved drugs (52)

• Acarbose
• Albiglutide
• Alogliptin benzoate
• Bexagliflozin
• Biotin
• Bromocriptine mesylate
• Canagliflozin
• Chlorpropamide
• Colesevelam hydrochloride
• Cyanocobalamin
• Dapagliflozin
• Dapagliflozin propanediol
• Dulaglutide
• Empagliflozin
• Ertugliflozin pidolate
• Exenatide
• Fenofibrate
• Fenofibric acid
• Finerenone
• Folic acid

Drugs in development (357)

• Acetaminophen Phase 1
• Acetylcarnitine Phase 2
• Acetylcholine Phase 2
• Acetylcysteine Early phase 1
• Acipimox Phase 2
• Aclimostat Phase 2
• Adomeglivant Phase 2
• ADP-597 Phase 1
• Alcohol Phase 2
• Aldafermin Phase 2
• Aleglitazar Phase 3
• Aliskiren Phase 1
• Allopurinol Phase 3
• Alogliptin Phase 3
• Amantadine Phase 2
• Amlodipine Phase 3
• Ampelopsin Phase 2
• Anagliptin Phase 3
• Arginine Phase 1
• Arhalofenate Phase 2

Other linked drugs (25)

• Amibegron
• Anakinra
• Arundic acid
• Cabergoline
• Cetilistat
• Ciprofloxacin
• Dexamethasone
• Edaglitazone
• Ertiprotafib
• Esomeprazole
• Glisoxepide
• Isosorbide mononitrate
• Losartan potassium
• Luseogliflozin
• Meglitinide
• Mirabegron
• Nitroprusside
• Pentaerythritol tetranitrate
• Polyethylene glycol
• Potassium